Though NF-κB inhibition repressed the growth of MCPyV+ MCC cells, the inhibitor used in these experiments was also toxic to other cell types, including MCPyV- MCC, making it unsuitable as a treatment strategy (Figs 5 and S4). The gene discussed is NFKB1; the disease is Merkel cell skin cancer.